Medicines

Here you will find the recommendations we have made about the use of individual medicines in Lancashire.

Ledipasvir / Sofosbuvir (Harvoni®)

Brand: Harvoni®
NICE TA: 363
Indication: Chronic hepatitis C (NICE TA363)
Disease category: Infections
Commissioning responsibility: NHS England
PbR excluded: Yes

Background

Ledipasvir / sofosbuvir is recommended as an option for treating chronic hepatitis C in adults (follow link to TA for circumstances where ledipasvir-sofosbuvir can be used).

It is recommended that the decision to treat and prescribing decisions are made by multidisciplinary teams in the operational delivery networks put in place by NHS England, to prioritise treatment for people with the highest unmet clinical need.

Decisions of Lancashire local decision making groups:

NHS Blackburn With Darwen CCG and NHS East Lancashire CCG NHS Blackpool CCG NHS Chorley and South Ribble CCG and NHS Greater Preston CCG NHS Fylde and Wyre CCG NHS Morecambe Bay CCG NHS West Lancashire CCG

Red

Red

Red

Red

Red

Red